+Search query
-Structure paper
Title | Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. |
---|---|
Journal, issue, pages | Nat Commun, Vol. 11, Page 4417-4417, Year 2020 |
Publish date | Mar 29, 2020 (structure data deposition date) |
Authors | Fu, L. / Ye, F. / Feng, Y. / Yu, F. / Wang, Q. / Wu, Y. / Zhao, C. / Sun, H. / Huang, B. / Niu, P. ...Fu, L. / Ye, F. / Feng, Y. / Yu, F. / Wang, Q. / Wu, Y. / Zhao, C. / Sun, H. / Huang, B. / Niu, P. / Song, H. / Shi, Y. / Li, X. / Tan, W. / Qi, J. / Gao, G.F. |
External links | Nat Commun / PubMed:32887884 |
Methods | X-ray diffraction |
Resolution | 1.35 - 2 Å |
Structure data | PDB-7bro: PDB-7brp: PDB-7c6s: PDB-7c6u: PDB-7d1m: |
Chemicals | ChemComp-HOH: ChemComp-U5G: ChemComp-K36: ChemComp-DMS: |
Source |
|
Keywords | VIRAL PROTEIN / 2019-nCoV main protease / The main protease of 2019-nCoV complexed with Boceprevir / SARS-CoV-2 / main protease / inhibitor / GC376 |